CellWell record HH-543059
Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials
Dana ElKhalifa; Nour Al-Ziftawi; Ahmed Awaisu; Feras Alali; Ashraf Khalil
2023
In plain language
Systematic review of eight randomized trials found sulforaphane significantly altered some cancer biomarkers while leaving others unchanged, with inconsistent PSA results across prostate cancer studies.
- Evidence
- Established
- Design
- Systematic review
Cite this record: https://thecellwell.org/studies/HH-543059
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.